<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<CIK> 0000830656
<NAME> BOSTON BIOMEDICA
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 260,273
<SECURITIES> 0
<RECEIVABLES> 7,120,606
<ALLOWANCES> (785,036)
<INVENTORY> 7,547,377
<CURRENT-ASSETS> 15,865,614
<PP&E> 14,337,246
<DEPRECIATION> (5,816,298)
<TOTAL-ASSETS> 27,265,878
<CURRENT-LIABILITIES> 10,981,565
<BONDS> 2,541,104
0
0
<COMMON> 56,145
<OTHER-SE> 13,282,869
<TOTAL-LIABILITY-AND-EQUITY> 27,265,878
<SALES> 6,136,942
<TOTAL-REVENUES> 14,584,721
<CGS> 3,018,033
<TOTAL-COSTS> 9,540,064
<OTHER-EXPENSES> 6,193,058
<LOSS-PROVISION> 60,398
<INTEREST-EXPENSE> (404,860)
<INCOME-PRETAX> (1,552,839)
<INCOME-TAX> 590,080
<INCOME-CONTINUING> (962,759)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (962,759)
<EPS-BASIC> (0.18)
<EPS-DILUTED> (0.18)
</TABLE>